These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9207880)

  • 41. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cancer of the larynx and the hypopharynx: anatomy, anatomopathology, clinical signals, TNM, therapy].
    Poissonnet G; Dassonville O; Pivot X; Demard F
    Bull Cancer; 2000 Dec; Suppl 5():27-38. PubMed ID: 11250600
    [No Abstract]   [Full Text] [Related]  

  • 43. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Airway obstruction due to lymphoma of the larynx and trachea.
    Hessan H; Houck J; Harvey H
    Laryngoscope; 1988 Feb; 98(2):176-80. PubMed ID: 3339928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of an organ conservation protocol in patients with locally advanced laryngeal tumours].
    León X; López M; García J; Quer M
    Acta Otorrinolaringol Esp; 2009; 60(3):176-85. PubMed ID: 19558903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent chemoradiotherapy as the most appropriate treatment for most T3 laryngeal carcinomas.
    Enepekides DJ
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):815-8. PubMed ID: 16172362
    [No Abstract]   [Full Text] [Related]  

  • 47. Radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin in the treatment of verrucous carcinoma of the head and neck.
    Strojan P; Soba E; Budihna M; Auersperg M
    J Surg Oncol; 2005 Dec; 92(4):278-83. PubMed ID: 16299796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Verrucous carcinoma of maxillary antrum.
    Indudharan R; Das PK; Thida T
    Singapore Med J; 1996 Oct; 37(5):559-61. PubMed ID: 9046219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
    Lefebvre JL; Ang KK;
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verrucous carcinoma of the larynx presenting as a hairy lesion.
    Triaridis S; Christoforidou A; Zarampoukas T; Vital V
    J Postgrad Med; 2014; 60(2):209-10. PubMed ID: 24823530
    [No Abstract]   [Full Text] [Related]  

  • 51. Laryngeal pleomorphic rhabdomyosarcoma.
    Schrock A; Jakob M; Zhou H; Bootz F
    Auris Nasus Larynx; 2007 Dec; 34(4):553-6. PubMed ID: 17481838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Laryngeal cancer in Murcia].
    Merino E; Hellín D; Girona JC; Arregui M; Jiménez-Cervantes J
    Acta Otorrinolaringol Esp; 1994; 45(1):37-40. PubMed ID: 8204292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of HHV-8 and HPV in laryngeal carcinoma.
    Güvenç MG; Midilli K; Ozdoğan A; Inci E; Tahamiler R; Enver O; Sirin G; Ergin S; Kuşkucu M; Divanoğlu EO; Yilmaz G; Altas K
    Auris Nasus Larynx; 2008 Sep; 35(3):357-62. PubMed ID: 17977679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
    Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pseudosarcoma of the larynx].
    Medina Sola JJ; Wienberg Ludwig P; Puente López G; Saiz Calleja MA; Dot Saldaña J; Grijalba Uche M
    An Otorrinolaringol Ibero Am; 1994; 21(2):169-75. PubMed ID: 8209969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of early-stage laryngeal cancer.
    Agrawal N; Ha PK
    Otolaryngol Clin North Am; 2008 Aug; 41(4):757-69, vi-vii. PubMed ID: 18570957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoradionecrosis of the hyoid induced by combined modality therapy for laryngeal carcinoma.
    Robertson JS; Frauenhoffer EE; Stryker J; Schaitkin B; Velkley DE; McGinn JD
    Ear Nose Throat J; 1995 Aug; 74(8):578-81. PubMed ID: 7555876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Unusual variant of laryngeal squamous cell carcinoma: verrucous carcinoma].
    Ruiz Gómez JM; Ballesteros JM; Vargas JL; Carvia R
    Acta Otorrinolaringol Esp; 1998 May; 49(4):325-8. PubMed ID: 9707746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor.
    Gillenwater A; Lewin J; Roberts D; El-Naggar A
    Laryngoscope; 2005 Jul; 115(7):1191-5. PubMed ID: 15995505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.